Dominant Male Behaviour Is Preventing Women in Africa From Protecting Their Own Sexual Health
Leeds Beckett UniversityA gel aimed at preventing HIV, which is being trialled in Africa, is only used by women with their male partner’s approval.
A gel aimed at preventing HIV, which is being trialled in Africa, is only used by women with their male partner’s approval.
A form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer, according to research published out of the George Washington University Cancer Center in Nature Communications.
Analysis of fatal and near-fatal physical abuse cases of children under 4 years of age revealed that psychosocial risk factors in the home, such as criminal history, were present in all cases. Two-thirds of the cases with prior medical records available (nine children) involved unexplained or atypical bruising – bruises on non-mobile infants, bruises on the ears, buttocks or eyes, and patterned bruises consistent with inflicted injury. All nine of these children suffered subsequent brain injury, resulting in four deaths. Findings were published in Child Abuse & Neglect.
Erectile dysfunction drugs such as Viagra and Cialis can cause an adverse reaction during surgery or other procedures requiring anesthesia. Anesthesia and nitric oxide, the key ingredient in Viagra and Cialis should NOT EVER be mixed.
Physician shares advice on how families can talk to dad and encourage him to take care of himself.
Most UTIs are caused by E. coli that live in the gut and spread to the urinary tract. A new study from Washington University School of Medicine in St. Louis has found that a molecular decoy can reduce the numbers of UTI-causing bacteria in the gut, potentially reducing the risk of recurrent UTI.
Peter Kanetsky, Ph.D., M.P.H., chair of the Cancer Epidemiology Department at Moffitt Cancer Center, and colleagues from the International TEsticular CAncer Consortium (TECAC), launched a large analysis of five major testicular cancer studies to investigate genetic risk factors linked to TGCT. Their results, which uncovered eight new genetic markers associated with TGCT, were published in the June 12 issue of Nature Genetics.
In a study published today in Cancer Cell, Moffitt Cancer Center researchers report that a newly discovered epigenetic mechanism can lead to the development of castration-resistant prostate cancer. They identified a novel drug that targets this epigenetic mechanism and may be able to combat the deadly form of the disease.
An analysis of data from five major studies of testicular cancer has identified new genetic locations that could be susceptible to inherited testicular germ cell tumors. The findings, which researchers call a success story for genome mapping, could help doctors understand which men are at the highest risk of developing the disease and signal them to screen those patients.
While the risk of developing testicular cancer is low, every man should understand some basic facts about this disease. Rutgers Cancer Institute of New Jersey experts share more about the disease, which is the most common malignancy among men ages 15 to 35.
Researchers at Leeds Beckett University, together with national charity, Fertility Network UK, are seeking men’s experiences of infertility as part of a new study.
UNC Lineberger Comprehensive Cancer Center surveyed 1,171 men diagnosed with prostate cancer in North Carolina, finding that while both white and black men were concerned about curing their cancer and the quality-of-life impacts of treatment, more black men considered other social and personal factors -- such as recovery time and cost -- to be very important in their treatment decision-making.
Physicians at UAB share tips on men’s health and how it affects heart health, sexual function and memory and decreases cancer risk.
New prostate cancer technology is improving the accuracy of biopsies. The technique fuses information from a prostate MRI to ultrasound images taken during the biopsy. The technique results in higher cancer detection, fewer biopsies and more accurate biopsies.
Use of the erectile dysfunction drug Viagra does not cause the development of melanoma, a deadly form of skin cancer.
A new study of obese people suggests that changes in their brains’ reward regions make them more prone to overeating, and that women and men exhibit different brain activity related to overeating.
An interim analysis of a phase I clinical trial examining a surgical procedure to remove the prostate and prostate cancer in men whose disease has spread (metastatic) shows the operation is safe and feasible in carefully selected patients.
A research team has engineered a small peptide that binds to a protein found in high-risk prostate cancers and can be imaged using MRI. The system identified aggressive tumors in mouse models of prostate cancer, and is a promising step for reliable early detection and treatment of high-risk, life-threatening prostate cancer.
Seattle Cancer Care Alliance experts are available to discuss new U.S. Preventive Services Task Force guidelines related to thyroid cancer screening for adults, risk factors and treatment options.
Researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy. The findings, based on a study in mice, could help to determine which patients should avoid anti-androgen therapy and identify new treatments for people with advanced prostate cancer.
Prostate HDR brachytherapy typically takes two to three hours. Patients usually go home from the hospital the same day. In contrast to permanent seed, or low-dose-rate brachytherapy, with HDR, no radioactive material is left inside the patient after the procedure. Because the radiation dose is delivered directly inside the prostate, radiation exposure to nearby critical structures, such as the bladder and rectum, is minimized.
Men over 50 have a higher risk than the general population of developing melanoma, the deadliest form of skin cancer, so they need to keep a sharp eye out for signs of the disease. Many women in this age group, however, would attest that they’re more likely than their male partners to notice suspicious spots on the skin — which means women could help save their male partners’ lives by helping them spot skin cancer.
New guidelines recommend that men aged 55 to 69 with no signs of prostate cancer have a conversation with their doctor about the benefits and drawbacks of screening for the disease.
Prostate cancer patients are willing to pay up to $2,000 of their own money for a new high-tech biopsy technique that significantly improves accuracy, according to a study published in the journal Urology Practice
This discovery, described online in the April 25 edition of eLife, will lead to important research and may one day help experts develop new and better therapies for Alzheimer's and other forms of cognitive decline.
Men who have sex with men (MSM) accounted for two thirds of all new HIV infections in the United States, with 26 percent occurring in Latinos, according to 2014 data. If those rates continue, it is estimated that one in four Latino MSM may be diagnosed with HIV during his lifetime.
According to the most recent statistics from the Centers for Disease Control and Prevention, 22 percent of new HIV diagnoses in the United States in 2014 occurred among young people ages 13 to 24, 80 percent of whom were gay and bisexual males.
Men who attended a structured yoga class twice a week during prostate cancer radiation treatment reported less fatigue and better sexual and urinary function than those who didn’t, according to a clinical trial led by the Perelman School of Medicine at the University of Pennsylvania. It is the first randomized trial to look at the effect of twice-weekly yoga on the side-effects and quality of life issues caused by prostate cancer treatment.
In 2016, more than 181,000 new cases of prostate cancer were reported in the U.S., according to the American Cancer Society. The prostate-specific antigen (PSA) test is one of the earliest ways clinicians can detect prostate cancers in their patients. Sometimes, a high PSA level may be a sign of benign conditions such as inflammation; therefore, more reliable tests are under investigation to help urologists diagnose and treat the disease in an aging population. Now, researchers at the University of Missouri have explored how a specific protein’s status may allow clinicians to better identify prostate cancer progression while helping them to make rational decisions in treating the disease.
A new study suggests that middle-age and elderly men are less likely to develop worsening frailty if they have high levels of certain anabolic hormones, which are muscle- and bone-building hormones. The study results will be presented Sunday at ENDO 2017, the Endocrine Society’s 99th annual meeting in Orlando, Fla.
Researchers have identified an apparent cause of inguinal hernia, or groin hernia, in older men: altered sex hormone levels that weaken and scar muscle tissue in the lower abdomen. Results of their study using an animal model will be presented Monday at ENDO 2017, the Endocrine Society’s 99th annual meeting in Orlando, Fla.
The natural fetal estrogen estetrol, also called E4, is being tested as a new drug that may help treat advanced prostate cancer, according to an ongoing industry-sponsored study from the Netherlands. The final results will be presented in a poster on Saturday, April 1, at ENDO 2017, the annual scientific meeting of the Endocrine Society, in Orlando, Fla.
Lindsey Konkel, a New Jersey-based freelance reporter, received the Endocrine Society’s annual Award for Excellence in Science and Medical Journalism, the Society announced today.
Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.
A new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy (ADT) – a testosterone-lowering therapy and a common treatment for the disease – and dementia, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.
News conferences will explore the latest research advances in obesity and diabetes technologies, thyroid conditions, men’s health and endocrine-disrupting chemicals at ENDO 2017, the Endocrine Society’s 99th Annual Meeting & Expo. The meeting will take place April 1–4 in Orlando, Fla.
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.
When small-molecule inhibitors proved elusive, researchers developed a novel strategy: Using large molecule peptides to target a common prostate cancer driver. It may provide a path for developing new therapies against a challenging target.